Legend Capital

Legend Capital, a subsidiary of Legend Holdings Ltd., was founded in April 2001 and is based in Beijing, China. The firm manages private equity investments across four funds, totaling up to US$700 million, focusing primarily on early-stage ventures and mid-market growth companies. Its investment strategy targets sectors including information technology, telecommunications, media, healthcare, consumer goods, clean technology, and advanced manufacturing, with a strong emphasis on businesses that are either based in China or related to Chinese markets. Legend Capital is known for its active involvement with portfolio companies, providing them with essential business resources and tailored services to enhance development and optimize company performance in the Chinese market. The firm has built a diverse portfolio of over 60 companies, contributing to its reputation as a respected player in China's venture capital industry.

Hao Chen

Vice Chairman

Rui Chen

Managing Director

Maggie Fu

Managing Director

Arthur Ge

Managing Director

Frank Hong

Managing Director

Xiaohong Huang

Managing Director

Yi Kang

Director

Richard Li

President

Jiaqing Li

Managing Director

Xiangyu Ouyang

Managing Director

Joon Sung Park

Managing Director

FAN Qihui

Executive Director

Hong Shangguan

Executive Director

Jenking Shao

Managing Director and Partner

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Piau-Voon Wang

Managing Director

Tony Wang

Managing Director and Vice President

Ge Xinyu

Managing Director

Joe Zhou

Managing Director

Hank Zhou

Managing Director and Co-Chief Investment Officer

Linan Zhu

Chairman

Past deals in Growth Stage

Bio-Engine

Series C in 2023
Bio-Engine specializes in the research and development of veterinary biological products, focusing on the creation and manufacturing of antibodies, recombinant proteins, and vaccines for both human and livestock viruses. The company utilizes high-density serum-free suspension culture technology for animal cells, which enhances the efficiency of its products. Key offerings include serum-free media for various cell types, such as HEK293 and PK15, applicable in fields like cell therapy and vaccine production. In addition to product development, Bio-Engine provides clinical trial services to pharmaceutical manufacturers and scientific research organizations. Founded in 2014 and headquartered in Shanghai, China, the company is committed to advancing biotechnological solutions in the veterinary sector.

TriApex

Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.

Tripod Preclinical Research

Funding Round in 2023
Tripod Preclinical Research is a Contract Research Organization that specializes in providing preclinical research services to the biopharmaceutical and medical device industries. The company offers a comprehensive range of services, including drug safety evaluation for new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Tripod's expertise encompasses non-human primate disease models, pharmacological efficacy studies, early drug evaluation, and Good Laboratory Practices (GLP) toxicology. Additionally, the organization supports translational medicine and clinical trials, along with biological analysis and the management of biological sample banks. By delivering these services, Tripod aids drug developers and researchers in advancing their projects through the critical early stages of research and development.

ZStack

Series C in 2023
ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

RUICYCLE

Series B in 2022
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company specializes in developing solutions for lithium battery recovery, encompassing cascade utilization, material regeneration, and new material recycling. RUICYCLE's innovative technologies offer industry users a closed-loop ecosystem that emphasizes automatic safe crushing and environmentally friendly treatment processes. By focusing on zero pollution and efficient recycling, RUICYCLE aims to address the challenges associated with lithium battery waste and contribute to sustainable practices in the industry.

Tianfu

Series C in 2022
Nanjing Tianfu Software Co., Ltd. is a developer of custom software solutions and intelligent industrial software based in Nanjing, China. Founded in 2011, the company serves various industries, including turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. Its offerings encompass a range of technical services, such as CAE pre- and post-processing development, special solver development, industrial design platform construction, and artificial intelligence platform development. Tianfu focuses on meeting the specific needs of its clients by providing tailored software solutions that enhance efficiency and innovation across different sectors.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of integrated circuit automatic test equipment, specializing in solutions for semiconductor manufacturers. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an City, Shanghai, and Suwon, South Korea, the company offers a range of products including test boards, software solutions, and memory systems. TBSTest Technology also provides pre-sales and after-sales support for its equipment, accessories, and software systems, catering to clients in integrated circuit design and production, as well as scientific research institutions and educational organizations. The company is dedicated to advancing testing technology for ultra-large-scale integrated circuits, ensuring high-quality performance for enterprise users in the semiconductor industry.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technology is a Chinese artificial intelligence (AI) chip maker

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

Inceptio Technology

Series B in 2022
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

Hoteam Software

Series C in 2022
Shandong Hoteam Software Co., Ltd, established in 1993 and based in Jinan, China, specializes in developing software products for the manufacturing sector. As a subsidiary of China Aerospace Science and Technology Corporation, the company focuses on providing industrial enterprises with comprehensive 3D-centric intelligent manufacturing solutions. Its software platforms encompass three-dimensional design, intelligent management, and visualization technologies, which aim to enhance work efficiency and reduce operational costs for clients engaged in collaborative research and development.

Singlomics

Series B in 2022
Singlomics is a biotechnology company that specializes in single-cell sequencing technology to facilitate antibody drug development aimed at treating infectious diseases and cancers. The company has made significant advancements in antibody discovery, having developed neutralizing antibodies such as DXP593 and DXP604, which offer potential solutions in the fight against COVID-19. By leveraging its innovative technology, Singlomics focuses on creating targeted therapies that address critical health challenges.

ZShield

Series C in 2022
ZShield Inc. provides cyberspace data security and big data business risk management. The company offers production innovation and data security services, information security platform, and AndunTM ZS-ISP which helps government and enterprises. The company was founded in 2014 and is based in Beijing, China.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Leapstack

Series C in 2021
Leapstack is an insurance technology company specializing in big data artificial intelligence technology. It is committed to building big data artificial intelligence solutions for commercial insurance companies and social security management agencies. The company was founded in February 2016 and has received angels from Gaochun Capital and Fumu Assets. It is headquartered in Shanghai and has offices in Beijing and Nanjing.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

River Security

Series C in 2021
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

Eswin

Series C in 2021
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.

Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. These services are designed to assist pharmaceuticals, biotechnology firms, and research institutions in achieving their drug discovery objectives. Biortus has established five advanced research platforms and has developed innovative techniques, some of which are patented. The company operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.

ForQaly

Series B in 2021
Developer of minimally invasive ventricular assist devices. The company's products with advantages of small trauma, large auxiliary flow, and easy to use, providing a circulation improvement plan that doctors can use conveniently and patients can afford.

H.Extract

Series C in 2021
H.Extract, established in 2010 and based in Qingdao, China, specializes in producing natural extracts from various spices such as pepper, ginger, garlic, and cumin for the food manufacturing sector. The company focuses on the research and development of high-quality extracts to meet the needs of food producers, enhancing flavor and nutritional value in their products. H.Extract is committed to maintaining industry standards and ensuring customer satisfaction through its innovative solutions and dedication to quality. With a growing reputation in the market, the company continues to expand its product offerings and strengthen its position within the food industry.

HC Scientific

Series B in 2021
HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

Mathpresso

Series C in 2021
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Yeasen

Series B in 2021
Developer and producer of enzymes and antibodies designed to serve in life science industry. The company is committed to research and development of enzymes and antibodies and providing high-quality products and services including reverse transcription, molecular cloning, and cell culture, enabling life scientist to facilitate their field research and enhance the advancement of life science.

RecBio

Series C in 2021
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Horizon Robotics

Series C in 2021
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

Bloks Technology Group

Series B in 2021
Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Fiture

Series B in 2021
Fiture is a fitness technology company focused on transforming home fitness through innovative hardware and artificial intelligence. The company offers customized online workout courses alongside the manufacturing of intelligent home workout equipment. By leveraging AI technologies, Fiture aims to enhance user experience and support clients in achieving healthier lifestyles through effective at-home fitness solutions.

Stonewise

Series B in 2021
Beijing StoneWise Technology Co., Ltd. is a technology company founded in 2018 that specializes in artificial intelligence-driven solutions for drug discovery. The company's platform integrates advanced technologies, including artificial intelligence, microfluidics, computational chemistry, and pharmacology, to enhance the efficiency and success rates of early-stage drug development. StoneWise focuses on the research and repurposing of nucleoside-based RNA polymerase inhibitors, particularly regarding their potential applications in treating COVID-19. The platform offers a variety of tools, such as medical knowledge graphs and molecular design capabilities, aimed at pharmaceutical enterprises and research institutions. By collaborating with both domestic and international experts in various scientific fields, StoneWise is committed to transforming traditional drug research methodologies and providing comprehensive solutions to improve drug discovery outcomes.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company specializing in the development and sale of protein and peptide drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company focuses on therapeutic areas such as diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neuro-degenerative conditions. Sciwind's innovative drug candidates are particularly targeted at metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for healthcare professionals and their patients.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Wangdiantong

Series C in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

GalaxySpace

Series C in 2020
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Aqrose Technology

Series B in 2020
Beijing Aqrose Technology Co., Ltd. is a high-tech company specializing in the research and development of computer vision and robotic technology for industrial automation. Founded in 2017, the company is based in Beijing, China, and leverages artificial intelligence to enhance manufacturing processes. Aqrose Technology offers a range of products, including an artificial intelligence deep learning visual inspection platform known as AIDI, which addresses industrial challenges such as defect detection and classification. The company also provides intelligent robots, like AIPICK, equipped with 3D vision technology and AI-based defect inspection systems. With a founding team originating from the Artificial Intelligence Laboratory of Tsinghua University, Aqrose Technology is committed to advancing industrial automation through innovative machine vision and machine learning solutions, thereby empowering advanced manufacturing and smart logistics sectors in China.

RecBio

Series B in 2020
Jiangsu Recbio Technology Co Ltd is a vaccine company dedicated to the development and commercialization of safer and more effective vaccines to address the far-unmet public needs. Hygiene needs. The company focuses on the R&D of HPV vaccine candidates. The company's vaccine portfolio currently consists of 12 vaccines, including three strategic products, namely REC603, a recombinant HPV 9-valent vaccine under phase III clinical trial.

Genskey

Series C in 2020
Beijing Genskey Technology Co., Ltd. is a medical diagnostic service provider specializing in genetic testing. Founded in 2007 and headquartered in Beijing, China, the company employs high-throughput sequencing technology combined with intelligent algorithm analysis to enhance pathogen diagnosis. Genskey aims to address common challenges in the medical diagnostics field, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of diagnostic results, Genskey seeks to ensure that patients suffering from severe infections receive prompt and accurate diagnoses, ultimately contributing to better health outcomes.
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

LEADRIVE

Series B in 2020
Leadrive Technology (Shanghai) Co.,Ltd. manufactures homebred power modules and electric vehicle solutions. The company offers products, such as Power Module, Power Control Unit, and Motor. Leadrive Technology (Shanghai) Co.,Ltd. was founded in 2017 and is based in Shanghai, China with additional offices in Shanghai, China; and Aachen, Germany.

Haihe Biopharma

Series B in 2020
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Tongcheng Shenghuo

Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Eswin

Series B in 2020
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.

Uditech

Series B in 2020
Shenzhen Uditech Co., Ltd. is a technology-driven company focused on the development and manufacture of robots for various service sectors, including restaurants, hospitals, and entertainment. Established in 2013 and headquartered in Shenzhen, China, Uditech's product offerings include robots equipped with advanced features such as face recognition, obstacle avoidance, multi-machine operation, food ordering and delivery, smart voice communication, and item transportation. In addition to robotics, the company also produces quad-core processors. With a commitment to innovation, Uditech aims to enhance service efficiency through its cutting-edge technology solutions.

iBeiDiao

Series B in 2020
iBeiDiao is a SaaS background check platform that combines with the Internet.

Wangdiantong

Series B in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

ANYCOLOR

Post in 2020
Ichikara Inc. is an entertainment start-up based in Tokyo, Japan, founded in 2017. The company specializes in creator support and licensing, primarily focusing on the management and operation of virtual streamers associated with the "Nijisanji Project." Ichikara offers a range of services, including access to distribution studios, advertising partnerships, event coordination, and opportunities for program appearances. Additionally, the company actively seeks to discover new talent through auditions, aiming to enhance the virtual entertainment landscape. By leveraging advanced technology, Ichikara strives to create engaging experiences that resonate with audiences globally.

Harbour BioMed

Series B in 2020
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases, particularly through immuno-oncology. Established in 2016 and headquartered in Shanghai, China, the company employs two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain only antibodies, enabling the creation of bispecific antibodies and other therapeutic compounds. Harbour BioMed's development pipeline includes products targeting various conditions, such as autoimmune diseases and respiratory infections. The company also licenses its antibody platforms to other firms and academic institutions via its Harbour Antibodies subsidiary. It has formed strategic collaborations with several notable organizations, including The Wistar Institute and WuXi Biologics, and maintains partnerships with various biopharmaceutical companies. With operations in Cambridge, Massachusetts, and antibody platform innovation in Rotterdam, the Netherlands, Harbour BioMed is positioned to enhance drug discovery and development across multiple global markets.

Genskey

Series B in 2020
Beijing Genskey Technology Co., Ltd. is a medical diagnostic service provider specializing in genetic testing. Founded in 2007 and headquartered in Beijing, China, the company employs high-throughput sequencing technology combined with intelligent algorithm analysis to enhance pathogen diagnosis. Genskey aims to address common challenges in the medical diagnostics field, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of diagnostic results, Genskey seeks to ensure that patients suffering from severe infections receive prompt and accurate diagnoses, ultimately contributing to better health outcomes.

Lunit

Series C in 2020
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

Nanovision

Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base with an additional subsidiary in Chengdu, specializes in high-speed and high-precision radiology imaging. The company focuses on the development of static CT, X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision created China's first self-developed CMOS flat panel detector, known as the Merak series. Its products are applicable in various sectors, including medical, industrial, and security, offering advanced technological support both domestically and internationally. With a significant research and development foundation, Nanovision is positioned as a key player in the radiation imaging industry.

Oriental Vision

Series C in 2019
Dongfang Weiyin is a financial service platform focused on small and micro enterprises. Established in 2015 and headquartered in Beijing, China, the company specializes in developing DFWYBANK.com, an accounting and tax database solution tailored for banks, tax bureaus, and small to medium-sized businesses. Through its services, Dongfang Weiyin aims to enhance financial management and compliance for its clients, contributing to the growth and sustainability of smaller enterprises in the Chinese market.

Suzhou Ribo Life Science

Series C in 2019
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.

RT-Thread

Series B in 2019
RT-Thread is a Shanghai-based company established in 2006 that specializes in developing an open-source real-time operating system (RTOS) for embedded devices. The RTOS is designed for a wide range of applications, particularly in the Internet of Things (IoT) sector, offering features such as cross-chip compatibility, cloud integration, ultra-low power consumption, and security. The system includes a device virtual file system, a device manager framework, low-power management, and firmware update capabilities. RT-Thread supports both resource-constrained microcontroller systems with its Nano version, which requires minimal memory, and more resource-rich IoT devices, allowing for modular customization through user-friendly tools. The company serves various industries, including new energy, home appliances, and transportation, providing a stable and scalable platform that facilitates easy access to major IoT cloud services.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd is a pet food manufacturer based in Liaocheng City, China, founded in 2006. The company specializes in a diverse range of products, including dry and wet pet food, real meat jerky treats, rawhide chews, and dental bones, catering to both dogs and cats. Its product lineup features various categories such as pet treats made from chicken, duck, pork, lamb, and fish, as well as wet food incorporating meat, fruits, and vegetables. Gambol Pet Group is committed to research and development, ensuring that its offerings include nutritional supplements and natural ingredients. The company distributes its products across Europe, Asia, and North America, serving a wide customer base. Under the leadership of Chairman and CEO Qin Hua, Gambol Pet Group continues to expand its presence in the pet food industry.

dMed

Series B in 2019
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Mathpresso

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

GKHT Medical Technology

Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd. was established in February 2013 and is affiliated to Oriental Science and Technology Holding Group Co., Ltd. (hereinafter referred to as “Oriental Instrument”), a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. It is headquartered in Yizhuang Economic and Technological Development Zone, Beijing. . Since the establishment of Guoke Hengtai for 4 years, the company has experienced two rounds of investment in A and B, and its performance has continued to grow at a high speed, with a compound annual growth rate of over 50%. In 2017, the company officially launched the IPO listing journey.

AgotoZ

Series B in 2019
AgotoZ Technology (Beijing) Co., Ltd., established in 2017, specializes in designing and developing software-defined wide-area networks (SD-WAN) that enhance TCP acceleration, WAN connectivity, and network security. The company focuses on providing an intelligent network transmission platform that integrates resource calculation and security defense capabilities. AgotoZ employs independent research and development to advance its core technologies, which include high-speed WAN transmission, big data computing, and security solutions. By offering efficient and high-speed interoperability platforms and related products, AgotoZ aims to meet the diverse network transmission needs of enterprises, enhancing their operational efficiency and security. The company is based in Beijing, China, and is recognized as a leader in its field.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Nanjing Inossem Software Technology Co., Ltd. provides enterprise application product development and consulting services. The company offers enterprise consulting services that include IT planning, supply chain consulting, ERP consulting, etc. It also focus on material management field of enterprises, and develops intelligent storage (Instock) and intelligent master data (Indata) based on the technical foundation of AI and IoT. The company was founded in 2015 and is based in Nanjing, China. It has additional offices in Canada, the United Kingdom, China, and Hong Kong.

Shuhai Supply Chain

Series B in 2019
Shuhai (Beijing) Supply Chain Management Co., Ltd., established in 2011 and headquartered in Beijing, China, specializes in providing comprehensive supply chain solutions tailored for the catering industry. The company offers a full range of services including sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality food. Shuhai operates a modern cold chain logistics center and food processing plants across the country, positioning itself as a leading enterprise in the supply chain sector. The company has earned recognition from industry authorities and clients alike, establishing itself as a benchmark in supply chain management.

Jiangrongxin Technology

Series B in 2019
Developer of financial and marketing software for consumer financial services enterprises. The company's credit card core system helps card issuers manage cardholder's credit and incentives, while their marketing platform can make purchase recommendations to consumers and track user retention.

River Security

Series B in 2019
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Zongmu

Series C in 2019
Zongmu Technology Co. Ltd, founded in January 2013 and headquartered in Shanghai, specializes in the development of advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has established itself as a leader in the SurroundView ADAS market within China, providing innovative solutions and integration services to various automotive manufacturers. Zongmu operates research and development centers in Beijing and Shenzhen, and has formed strategic partnerships with numerous original equipment manufacturers (OEMs) and their tier-one suppliers. Its product offerings include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems, all aimed at enhancing vehicle safety and improving the driving experience.

DeepWise

Series C in 2019
Beijing Deepwise Science And Technology Co., Ltd. develops an artificial intelligence (AI) based medical application software that provides clinical imaging analysis and clinical diagnostics. The company offers early screening and diagnosis of various malignant diseases. It serves to hospitals, medical centers, and third party imaging centers. The company was founded in 2017 and is based in Beijing, China.

Bangsun Technology

Series C in 2019
Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.

New Horizon Health

Series C in 2019
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

Black Sesame Technologies

Series B in 2019
Black Sesame Technologies is an artificial intelligence company that specializes in digital imaging technology and solutions for various real-world AI challenges. Founded in 2016, the company operates from locations in Silicon Valley and Shanghai. It focuses on developing image processing algorithms and embedded sensing platforms tailored for applications in smartphones, autonomous driving, and consumer electronics. The firm engages in extensive research and development, including core algorithm development, ASIC design, and engineering applications for advanced driver-assistance systems (ADAS). Black Sesame Technologies is committed to scientific and technological innovation, emphasizing quality and reliable service to deliver high-quality technology and applications. Additionally, it has designed automotive-grade system-on-chip (SoC) solutions aimed at enhancing the future of mobility through advanced computing capabilities.

Likechuxing

Series B in 2019
Traveling immediately is a car sharing travel service platform taking advantage of the tide of sharing economy. By deep integration of mobile Internet and car time-sharing, it breaks the traditional car travel mode and serves the needs of short-haul travel within the city. Travel APP immediately combines the depth of the mobile Internet with the time-sharing of cars. The user can realize the intelligent operation of the whole process of the car at any time through the APP, and only need to bear the mileage and long-term cost. “Travel immediately” changed the way traditional car trips and car rentals.
Shanghai Cell Therapy Group Co., Ltd., established in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company provides technical services and consulting, as well as technology transfer and investments within the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on areas such as cellular cold storage and cellular pharmaceuticals. Additionally, Shanghai Cell Therapy Group facilitates genetic testing for patients and supports cancer facilities by supplying essential research data.

SAFE Pharmaceutical

Series C in 2018
SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.
Shanghai Cell Therapy Group Co., Ltd., established in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company provides technical services and consulting, as well as technology transfer and investments within the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on areas such as cellular cold storage and cellular pharmaceuticals. Additionally, Shanghai Cell Therapy Group facilitates genetic testing for patients and supports cancer facilities by supplying essential research data.

Akulaku

Series C in 2018
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.

Udesk

Series C in 2018
Udesk Ltd. is a customer experience solution provider based in Beijing, China, founded in 2014. The company specializes in creating an integrated platform that facilitates omnichannel communication, connecting various customer interaction channels such as call centers, online services, and work order systems. Udesk leverages cloud computing, big data, and artificial intelligence to enhance customer service efficiency, reduce operational costs, and improve customer satisfaction across diverse industries, including healthcare, retail, logistics, and banking. The platform supports multiple applications through features like text and voice robots, agent assistance, and quality inspection. Udesk has successfully attracted over 70,000 registered enterprise users, including high-profile clients like Starbucks and Procter & Gamble, establishing itself as a leader in the customer service SaaS sector. The company has received significant investment to support its research and development efforts, positioning it well for growth in the expanding digital customer service market.

Zhenkunhang

Series C in 2018
Zhenkunhang, also known as Qingdao Zhenkun Trading, is an e-commerce platform for industrial products, including maintenance, operation, and repair (MRO) products. Zhenkunhang was founded in 1996. Qingdao Zhenkun Trading is a professional lubricant, adhesive, fasteners, and related equipment suppliers, is committed to providing customers with a full range of bonding and sealing, lubrication, fastening solutions. We work with a number of internationally renowned brands to creatively combine different suppliers and our own unique technologies and products to provide our customers with the most suitable solutions. Fastener products cover all types of fasteners in the world today, mainly including: hexagon socket head cap screws, hexagonal screws, stop screws (top screws), various mechanism screws, self tapping screws, nuts, various washers, Rivets, pins, splines, tools for the above products, nylon lock (tie), etc., and we offer products of different materials (carbon steel, stainless steel, copper, aluminum) We can provide DIN, ISO, NFE, JIS, ANSI, BS, GB different brand and non-brand fasteners according to your requirements.

Zhenkunhang

Series C in 2018
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Harbour BioMed

Series B in 2018
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases, particularly through immuno-oncology. Established in 2016 and headquartered in Shanghai, China, the company employs two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain only antibodies, enabling the creation of bispecific antibodies and other therapeutic compounds. Harbour BioMed's development pipeline includes products targeting various conditions, such as autoimmune diseases and respiratory infections. The company also licenses its antibody platforms to other firms and academic institutions via its Harbour Antibodies subsidiary. It has formed strategic collaborations with several notable organizations, including The Wistar Institute and WuXi Biologics, and maintains partnerships with various biopharmaceutical companies. With operations in Cambridge, Massachusetts, and antibody platform innovation in Rotterdam, the Netherlands, Harbour BioMed is positioned to enhance drug discovery and development across multiple global markets.

Urotronic

Series B in 2018
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, founded in 2014. The company specializes in developing innovative solutions for urology, particularly in the treatment of urethral blockages. Its flagship product, Optilume, is a drug-coated balloon catheter designed to treat urethral strictures in men. This device combines balloon dilation with localized drug delivery, utilizing the drug paclitaxel to inhibit cell proliferation and reduce the formation of scar tissue that can lead to stricture recurrence. By effectively covering the affected area during the procedure, Optilume offers a low-cost, minimally-invasive treatment option for patients suffering from urinary tract conditions, catering primarily to urologists and their patients.

Spacety

Series B in 2018
Spacety is a microsatellite start-up that specializes in developing commercial micro/nano-satellites. It provides short-cycle, low-cost, and one-stop services to scientists, research institutes, and commercial companies, for science experiments and technology demonstrations. At present, the company has launched four commercial microsatellites and aims for more in the future. The company was founded in January 2016 with headquarters in Changsha, China.

Lunit

Series B in 2018
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

Aikucun

Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.

Zongmu

Series C in 2018
Zongmu Technology Co. Ltd, founded in January 2013 and headquartered in Shanghai, specializes in the development of advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has established itself as a leader in the SurroundView ADAS market within China, providing innovative solutions and integration services to various automotive manufacturers. Zongmu operates research and development centers in Beijing and Shenzhen, and has formed strategic partnerships with numerous original equipment manufacturers (OEMs) and their tier-one suppliers. Its product offerings include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems, all aimed at enhancing vehicle safety and improving the driving experience.

Paixue Che

Series B in 2018
Pai Xueche is an Internet driving training platform. The school adopts a consultant tracking system throughout the process. The company will equip each student with an exclusive learning car consultant, from registration to the student's driver's license, the whole process of tracking.

Taihe Music Group

Series C in 2018
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.

Enjoy Dental Clinic

Series B in 2018
Enjoy Dental Clinic, founded in 2007 and based in Beijing, China, specializes in providing dental care services. The clinic offers a range of dental treatments while also focusing on dental clinic franchising. This includes providing essential services such as dental training, clinic construction, and investment support. Through these offerings, Enjoy Dental Clinic enables aspiring dentists to gain professional training and operational experience in running a dental practice.

Nattitude

Series B in 2018
An E-commerce Platform based in Guangzhou,China.

JollyChic

Series C in 2018
Jollychic EC Limited is an online retail platform that offers a diverse range of products, including clothing, shoes, bags, baby items, electronics, home goods, and various accessories. Established in 2012 and headquartered in Birkirkara, Malta, Jollychic aims to provide customers with a convenient shopping experience through its extensive selection of stylish and quality products. The platform features categories such as apparel, sports goods, toys, bedding, wedding supplies, cleaning tools, and kitchen appliances, making it a comprehensive destination for consumers seeking a variety of goods in one place.

NewsDog

Series C in 2018
NewsDog operates as a news and entertainment content aggregator, focusing on both Indian and international markets. The company has developed a platform known as WeMedia, which facilitates content submission from users and has garnered a community of over 30,000 regular contributors. By leveraging machine learning technology, NewsDog curates personalized news experiences for its users, allowing them to access updated information efficiently. The company faces competition from other content aggregators, including Dailyhunt, Inshorts, and NewsPoint.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.